FDA New, GMP Do
Clinical Phase II, III Intermediates
GMP Custom synthesis, Full Document
R&D Center: 8000 sq, More than 100 hoods
Pilot Plant: 20000sq, 40 reactors from 5-200L
Manufacturing Site: 800000sq, 40 reactors from 100-5000L
Web: www.eosmedchem.com
This is my R&D youtube: https://youtu.be/r5cJdXKNXHk
| LY-223982, 117423-74-2, LY-223982 Intermediate 70311-27-2, stock 764.1g, white powder, assay by HPLC 99%, HNMR, LCMS we supply. |
| LY-223982, 117423-74-2, LY-223982 Intermediate 67326-20-9, stock 886.5g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
| LY-223982, 117423-74-2, LY-223982 Intermediate 117424-79-0, stock 683.3g, white powder, assay by HPLC 98.7%, HNMR, LCMS we supply. |
| LY-223982, 117423-74-2, LY-223982 Intermediate 117424-80-3, stock 995.1g, white powder, assay by HPLC 98.6%, HNMR, LCMS we supply. |
| LY-223982, 117423-74-2, LY-223982 Intermediate 128578-16-5, stock 356.4g, white powder, assay by HPLC 99.7%, HNMR, LCMS we supply. |
| LY-223982, 117423-74-2, LY-223982 Intermediate 134578-03-3, stock 933g, white powder, assay by HPLC 98.2%, HNMR, LCMS we supply. |
| LY-223982, 117423-74-2, LY-223982 Intermediate 128577-80-0, stock 809.1g, white powder, assay by HPLC 98.2%, HNMR, LCMS we supply. |
| LY-223982, 117423-74-2, LY-223982 Intermediate 117423-74-2, stock 870.9g, white powder, assay by HPLC 99.3%, HNMR, LCMS we supply. |
